Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort.

Patel SP, Fisher J, Chae YK, Soto LS, Kasi A, Konda B, Walshauser M, Parra E, Zhang J, Duault C, Gonzalez-Kozlova E, Manyam G, Zhang J, Chen H, Duose DY, Laberiano Fernandez C, Luthra R, Al-Atrash G, Kim-Schulze S, Maecker HT, Wistuba II, Gnjatic S, Lee JJ, Zhang J, Magner CM, Chen HX, Sharon E, Othus M, Ryan CW, Blanke C, Haymaker CL, Kurzrock R

Open source

DOI: 10.1136/jitc-2025-011760
Published: 2025 Jun 30
Container: Journal for immunotherapy of cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2025-011760,
  title = {Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort.},
  author = {Patel SP and Fisher J and Chae YK and Soto LS and Kasi A and Konda B and Walshauser M and Parra E and Zhang J and Duault C and Gonzalez-Kozlova E and Manyam G and Zhang J and Chen H and Duose DY and Laberiano Fernandez C and Luthra R and Al-Atrash G and Kim-Schulze S and Maecker HT and Wistuba II and Gnjatic S and Lee JJ and Zhang J and Magner CM and Chen HX and Sharon E and Othus M and Ryan CW and Blanke C and Haymaker CL and Kurzrock R},
  year = {2025},
  journal = {Journal for immunotherapy of cancer},
  doi = {10.1136/jitc-2025-011760},
  url = {https://doi.org/10.1136/jitc-2025-011760}
}

RIS

TY  - JOUR
TI  - Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort.
AU  - Patel SP
AU  - Fisher J
AU  - Chae YK
AU  - Soto LS
AU  - Kasi A
AU  - Konda B
AU  - Walshauser M
AU  - Parra E
AU  - Zhang J
AU  - Duault C
AU  - Gonzalez-Kozlova E
AU  - Manyam G
AU  - Zhang J
AU  - Chen H
AU  - Duose DY
AU  - Laberiano Fernandez C
AU  - Luthra R
AU  - Al-Atrash G
AU  - Kim-Schulze S
AU  - Maecker HT
AU  - Wistuba II
AU  - Gnjatic S
AU  - Lee JJ
AU  - Zhang J
AU  - Magner CM
AU  - Chen HX
AU  - Sharon E
AU  - Othus M
AU  - Ryan CW
AU  - Blanke C
AU  - Haymaker CL
AU  - Kurzrock R
PY  - 2025
JO  - Journal for immunotherapy of cancer
DO  - 10.1136/jitc-2025-011760
UR  - https://doi.org/10.1136/jitc-2025-011760
ER  -

APA

SP, P., J, F., YK, C., LS, S., A, K., B, K., M, W., E, P., J, Z., C, D., E, G., G, M., J, Z., H, C., DY, D., C, L. F., R, L., G, A., S, K., HT, M., II, W., S, G., JJ, L., J, Z., CM, M., HX, C., E, S., M, O., CW, R., C, B., CL, H., & R, K. (2025). Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort.. Journal for immunotherapy of cancer. https://doi.org/10.1136/jitc-2025-011760

Source records

pubmed · retrieved 2026-09-27T13:10:25.353Z